3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 1
2
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Multiple Myeloma
168
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Recurrence
28
Leukemia
24
Vomiting
23
Neoplasms, Plasma Cell
20
Lymphoma
18
Neoplasms
16
Nausea
13
Burkitt Lymphoma
11
Prostatic Neoplasms
8
Immunoglobulin Light-chain Amyloidosis
7
Carcinoma, Non-Small-Cell Lung
6
Lymphoma, Follicular
5
Lung Neoplasms
5
Hodgkin Disease
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Small Cell Lung Carcinoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Paraproteinemias
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Fallopian Tube Neoplasms
3
Interventions
Doxorubicin
25
Ifosfamide
22
Radiotherapy
17
Etoposide
11
Vincristine
10
Cyclophosphamide
10
Filgrastim
8
Dactinomycin
8
Trabectedin
7
Chemotherapy, Adjuvant
5
pazopanib
4
Cisplatin
4
Topotecan
3
Radiation
3
Neoadjuvant Therapy
3
Irinotecan
3
Granulocyte Colony-Stimulating Factor
3
Dacarbazine
3
sargramostim
2
etoposide phosphate
2
eribulin
2
Observation
2
Methotrexate
2
Mesna
2
Imatinib Mesylate
2
Gemcitabine
2
Epirubicin
2
Docetaxel
2
Dexrazoxane
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sarcoma
×
Dexamethasone
×
Clear all
NCT02672527
2018-08-16
TSAR
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
Completed
103 enrolled